CJC 1295(without DAC) & IPA blend

The CJC 1295 (without DAC) & Ipamorelin blend is one of the most popular synergistic combinations in the field of growth hormone research. This formulation pairs a Growth Hormone Releasing Hormone (GHRH) analog with a Growth Hormone Releasing Peptide (GHRP). While CJC 1295 acts as a signaling agent to stimulate the pituitary gland to produce growth hormone, Ipamorelin mimics ghrelin and acts as a potent GH secretagogue that suppresses somatostatin (the hormone that inhibits GH release). By attacking the growth hormone production process from two different biological angles, this blend facilitates a significantly more powerful and natural-looking growth hormone pulse than either peptide used in isolation.

Scientific research into this specific blend focuses on its ability to optimize body composition by accelerating fat loss and supporting the development of lean muscle mass. Because both components have relatively short half-lives, they mimic the body’s natural circadian GH secretion patterns without causing the permanent “bleed” of growth hormone associated with long-acting versions. This makes the blend a primary subject for studies on cellular repair, anti-aging, and metabolic efficiency. Furthermore, Ipamorelin is noted for its high selectivity, meaning it does not significantly increase hunger or cortisol levels, allowing researchers to study pure growth hormone elevation. This highly purified blend is an essential tool for understanding complex endocrine synergies and their impact on systemic rejuvenation.